Heidelberg, Germany

Mathias Heikenwälder

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mathias Heikenwälder: Innovator in Hepatology Research

Introduction

Mathias Heikenwälder, based in Heidelberg, Germany, is a prominent inventor in the field of hepatology. He has made significant contributions to the understanding and treatment of liver diseases, particularly in relation to non-alcoholic steatohepatitis (NASH). With two patents under his name, Heikenwälder is paving the way for innovative therapies that may transform how NASH is treated.

Latest Patents

Mathias Heikenwälder's latest patents focus on novel compounds that target thrombocyte activity and aggregation capacity through cellular components. These inventions are particularly aimed at treating diseases associated with Non-Alcoholic Fatty Liver Disease (NAFLD). His groundbreaking work seeks to address NASH, a progressive stage of NAFL, in order to prevent serious complications such as liver cirrhosis and Hepatocellular Carcinoma (HCC). The patents also outline pharmaceutical compositions that comprise these compounds, alongside methods for screening new therapeutics aimed at combating NASH.

Career Highlights

Heikenwälder currently works at the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts, an esteemed research institution focused on cancer research. His role at this institution allows him to leverage his expertise in liver diseases and collaborate closely with other leading researchers in the field.

Collaborations

Throughout his career, Mathias Heikenwälder has collaborated with notable colleagues, including Lars Zender and Achim Weber. These partnerships foster an environment of innovation and research excellence, aiming to advance treatment methodologies for liver diseases.

Conclusion

Mathias Heikenwälder stands out as an influential inventor dedicated to improving the landscape of liver disease treatment. His patents reflect a commitment to developing novel therapeutics that address critical medical challenges. As the understanding of NASH evolves, the contributions of inventors like Heikenwälder will play a pivotal role in enhancing patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…